Racial and ethnic disparities in a national cohort of ampullary cancer patients

Racial and ethnic variations have been described in the different malignancies, but no such data exists for ampullary cancer. The aim of this study was to present an updated report on the epidemiology, treatment patterns, and survival of a national cohort of ampullary cancer patients.

[1]  Kassandra I. Alcaraz,et al.  Cancer statistics for African Americans, 2016: Progress and opportunities in reducing racial disparities , 2016, CA: a cancer journal for clinicians.

[2]  C. Jackson,et al.  Health disparities in colorectal cancer among racial and ethnic minorities in the United States. , 2016, Journal of gastrointestinal oncology.

[3]  A. Maitra,et al.  Validation of histomolecular classification utilizing histological subtype, MUC1, and CDX2 for prognostication of resected ampullary adenocarcinoma , 2015, British Journal of Cancer.

[4]  L. Borsu,et al.  Sequencing of 279 cancer genes in ampullary carcinoma reveals trends relating to histologic subtypes and frequent amplification and overexpression of ERBB2 (HER2) , 2015, Modern Pathology.

[5]  O. Olopade,et al.  A perfect storm: How tumor biology, genomics, and health care delivery patterns collide to create a racial survival disparity in breast cancer and proposed interventions for change , 2015, CA: a cancer journal for clinicians.

[6]  S. Wheeler,et al.  Health disparities across the breast cancer continuum. , 2015, Seminars in oncology nursing.

[7]  C. Yang,et al.  Long-term prognosis of surgical treatment for early ampullary cancers and implications for local ampullectomy , 2015, BMC Surgery.

[8]  B. Gayet,et al.  Predictors of Long-Term Survival Following Resection for Ampullary Carcinoma: A Large Retrospective French Multicentric Study , 2014, Pancreas.

[9]  L. Robison,et al.  Genomics of racial and ethnic disparities in childhood acute lymphoblastic leukemia , 2014, Cancer.

[10]  Song-Cheol Kim,et al.  Increased number of metastatic lymph nodes in adenocarcinoma of the ampulla of Vater as a prognostic factor: a proposal of new nodal classification. , 2014, Surgery.

[11]  Timothy B. Smith,et al.  Hispanic mortality paradox: a systematic review and meta-analysis of the longitudinal literature. , 2013, American journal of public health.

[12]  S. Morini,et al.  Carcinoma of the Ampulla of Vater: Morphological and Immunophenotypical Classification Predicts Overall Survival , 2013, Pancreas.

[13]  O. Clausen,et al.  Intestinal-type and Pancreatobiliary-type Adenocarcinomas: How Does Ampullary Carcinoma Differ from Other Periampullary Malignancies? , 2013, Annals of Surgical Oncology.

[14]  M. Büchler,et al.  Effect of adjuvant chemotherapy with fluorouracil plus folinic acid or gemcitabine vs observation on survival in patients with resected periampullary adenocarcinoma: the ESPAC-3 periampullary cancer randomized trial. , 2012, JAMA.

[15]  M. Choti,et al.  Clinicopathologic Analysis of Ampullary Neoplasms in 450 Patients: Implications for Surgical Strategy and Long-Term Prognosis , 2010, Journal of Gastrointestinal Surgery.

[16]  D. Henson,et al.  Cancers of the ampulla of vater: Demographics, morphology, and survival based on 5,625 cases from the SEER program , 2009, Journal of surgical oncology.

[17]  R. Zellars,et al.  African American women who receive primary anthracycline- and taxane-based chemotherapy for triple-negative breast cancer suffer worse outcomes compared with white women. , 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  L. Way,et al.  Tumors of the ampulla of vater: histopathologic classification and predictors of survival. , 2008, Journal of the American College of Surgeons.

[19]  B. Feig,et al.  The impact of ethnicity on the presentation and prognosis of patients with gastric adenocarcinoma , 2008, Cancer.

[20]  C. Ko,et al.  Survival After Resection of Ampullary Carcinoma: A National Population-Based Study , 2008, Annals of Surgical Oncology.

[21]  M. Goodman,et al.  Descriptive study of gallbladder, extrahepatic bile duct, and ampullary cancers in the United States, 1997–2002 , 2007, Cancer Causes & Control.

[22]  J. Donohue,et al.  Adjuvant therapy for ampullary carcinomas: the Mayo Clinic experience. , 2006, International journal of radiation oncology, biology, physics.

[23]  A. Stewart,et al.  Adjuvant chemotherapy for stage III colon cancer: implications of race/ethnicity, age, and differentiation. , 2005, JAMA.

[24]  Colin B Begg,et al.  Survival of blacks and whites after a cancer diagnosis. , 2002, JAMA.

[25]  E. Rosato,et al.  Outcome of pancreaticoduodenectomy and impact of adjuvant therapy for ampullary carcinomas. , 2000, International journal of radiation oncology, biology, physics.

[26]  J. Faivre,et al.  Cancer of the ampulla of Vater: results of a 20‐year population‐based study , 2000, European journal of gastroenterology & hepatology.

[27]  F. Marshall,et al.  The national cancer data base , 1997, Cancer.

[28]  P. Wingo,et al.  Cancer statistics for African Americans, 1996 , 1996, CA: a cancer journal for clinicians.